• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New VITAS® Healthcare Video Honors Caregiver's Journey and the Power of Hospice at Home

    11/25/25 10:50:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email

    Stacy Noland reveals how VITAS brought comfort and dignity during her mother's final days.

    MIRAMAR, Fla., Nov. 25, 2025 /PRNewswire/ -- A new video released by VITAS Healthcare during National Care at Home Month spotlights the hospice story of Stacy Noland and her mother, Sonia Lindo, whose final chapter was marked by compassion and dignity. The expert end-of-life care they received allowed Noland to focus on what mattered most: being a daughter.

    Lindo, a Jamaican-born cardiac nurse of 30 years saved countless lives before facing her own terminal diagnosis. "When my mother got sick, it stunned me," Noland said. "She was strong, healthy and dedicated to her patients. For her to just get cancer, it was devastating, to say the least."

    As Lindo's sole caregiver, Noland faced overwhelming strain until a hospital physician suggested hospice care. The arrival of the VITAS care team transformed their experience. "It gave me time to be with my mother. I felt closest to her during that time," she recalled.

    Through hospice care at home, Lindo received comfort and dignity surrounded by the same compassion she had shown others throughout her career. "The comforting part about the hospice care was the nurses that they sent," said Noland. "Once VITAS sent Miss Jennifer, it just made it that much less of a burden for me because I felt so comfortable with her right away."

    The cultural connection and immediate trust brought a sense of calm and relief to the home. The team often went beyond clinical duties to provide holistic support. "I came home one day, and they were cleaning, mopping, playing music… I was so overwhelmed," Noland shared. "They just took care of everything."

    Hospice care at home offers a person- and family-centered model that allows seriously ill patients to spend their final months, weeks and days in comfort, surrounded by loved ones. Research shows hospice improves quality of life, reduces hospitalizations and helps families focus on what matters most.

    "Stories like Stacy's remind us of what compassionate care truly means," said Patty Husted, executive vice president of patient and family supportive services at VITAS. "Hospice care at home surrounds patients and families with holistic support, especially when caregivers don't have extended family or other means of support."

    Each November, National Care at Home Month honors the dedicated, patient-centered care that healthcare professionals provide in homes across the country. Testimonials like Noland's demonstrate the value of the interdisciplinary hospice team, which includes a nurse, physician, hospice aide, social worker, volunteer, chaplain and bereavement specialist.

    Watch Stacy's story and hear how quality end-of-life care makes a difference for patients and their loved ones. Learn more about hospice care at home at VITAS.com or call 800.93.VITAS.

    About VITAS® Healthcare

    VITAS Healthcare is the nation's leading provider of end-of-life care. For almost 50 years, VITAS (pronounced VEE-tahs) has delivered compassionate hospice and palliative care to seriously ill patients and their families. Headquartered in Miramar, Florida, the company operates 59 service areas across 15 states (Alabama, California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS cares for more than 22,000 patients daily, primarily wherever they call home, as well as in its inpatient hospice settings and through partnerships with hospitals, nursing homes and assisted living communities. With a team of nearly 12,000 employees, VITAS was named a 2025 Top Workplace in Healthcare. Visit www.vitas.com.

    Media inquiries contact: [email protected], 877-848-2701

    Established in 1978, VITAS Healthcare is the nation's leading provider of end-of-life care. For more information, visit VITAS.com. (PRNewsfoto/VITAS Healthcare)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/new-vitas-healthcare-video-honors-caregivers-journey-and-the-power-of-hospice-at-home-302625826.html

    SOURCE VITAS Healthcare

    Get the next $CHE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    2/27/2026$422.00Outperform → Sector Perform
    RBC Capital Mkts
    1/22/2026$475.00Buy → Hold
    Jefferies
    9/2/2025$550.00Hold → Buy
    Jefferies
    7/25/2025$500.00Hold
    Jefferies
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement

    CINCINNATI, April 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into an Amended and Restated Credit Agreement for its Credit Facility ("Credit Agreement"). JPMorgan Chase Bank, N.A., acted as the Administrative Agent, Joint Lead Arranger and Joint Bookrunner for this transaction. Bank of America, N.A., was Joint Lead Arranger, Joint Bookrunner and Syndication Agent and PNC N.A. and U.S. Bank N.A. were Co-Documentation Agents. Terms of the Credit Agreement consist of a five-year $450 million revolving credit facility including $100 million for letters of credit. The interest rate on this Credit Agreement has a floating rate that is gene

    4/13/26 8:15:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24

    CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, April 24, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/o65jro38. Participants may

    4/1/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Roto-Rooter Completes Acquisitions for Two Significant Territories

    CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- On March 31, Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE) announced it has purchased the territory and assets of the franchises operating in San Francisco, California and Fort Worth, Texas in two separate transactions. The aggregated, combined purchase price of these transactions was approximately $20.6 million. Collectively, these Roto-Rooter locations serve a population of approximately 3.3 million people. This purchase is part of Roto-Rooter's ongoing strategy of acquiring franchises to boost productivity, market share and profitability. Listed on the New York Stock Exchange and head

    4/1/26 10:17:21 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemed downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Chemed from Outperform to Sector Perform and set a new price target of $422.00

    2/27/26 8:26:46 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed downgraded by Jefferies with a new price target

    Jefferies downgraded Chemed from Buy to Hold and set a new price target of $475.00

    1/22/26 8:25:02 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed upgraded by Jefferies with a new price target

    Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00

    9/2/25 8:21:04 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mcnamara Kevin J

    4 - CHEMED CORP (0000019584) (Issuer)

    3/30/26 12:42:06 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    President and CEO Mcnamara Kevin J sold $806,360 worth of Capital Stock (2,000 units at $403.18), decreasing direct ownership by 2% to 93,719 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    3/13/26 12:11:01 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Executive vice president Lee Spencer S exercised 499 units of Capital Stock at a strike of $469.56 and covered exercise/tax liability with 154 units of Capital Stock, increasing direct ownership by 2% to 14,912 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    2/17/26 4:50:05 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Walsh George J Iii bought $83,420 worth of Capital Stock (200 units at $417.10), increasing direct ownership by 6% to 3,523 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    8/5/25 3:24:17 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

    4 - CHEMED CORP (0000019584) (Issuer)

    12/30/24 11:10:35 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    SEC Filings

    View All

    Chemed Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - CHEMED CORP (0000019584) (Filer)

    4/13/26 9:03:49 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form DEFR14A filed by Chemed Corp

    DEFR14A - CHEMED CORP (0000019584) (Filer)

    4/9/26 10:42:16 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form DEF 14A filed by Chemed Corp

    DEF 14A - CHEMED CORP (0000019584) (Filer)

    4/6/26 9:00:25 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Financials

    Live finance-specific insights

    View All

    Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24

    CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, April 24, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/o65jro38. Participants may

    4/1/26 12:00:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Reports Fourth-Quarter 2025 Results

    CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the fourth quarter of 2024GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0%Adjusted Diluted EPS of $6.42, a decrease of 6.0% VITAS s

    2/25/26 4:15:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents

    CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on March 13, 2026, to shareholders of record as of February 23, 2026. This is equal to the dividend paid in December 2025. This represents the 219th consecutive quarterly dividend

    2/13/26 1:20:02 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/13/24 5:01:01 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/23 11:12:43 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Chemed Corp (Amendment)

    SC 13G/A - CHEMED CORP (0000019584) (Subject)

    2/9/22 3:33:36 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    View All

    VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer

    MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform

    7/30/25 4:22:59 PM ET
    $CHE
    Medical/Nursing Services
    Health Care

    VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

    VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

    3/13/24 9:00:00 AM ET
    $CHE
    Medical/Nursing Services
    Health Care

    Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

    Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

    12/18/23 1:20:00 PM ET
    $CHE
    Medical/Nursing Services
    Health Care